Logo image of SPAI

SAFE PRO GROUP INC (SPAI) Stock Fundamental Analysis

USA - NASDAQ:SPAI - US78642D1019 - Common Stock

7.11 USD
+0.16 (+2.3%)
Last: 9/22/2025, 1:58:08 PM
Fundamental Rating

2

Overall SPAI gets a fundamental rating of 2 out of 10. We evaluated SPAI against 69 industry peers in the Aerospace & Defense industry. The financial health of SPAI is average, but there are quite some concerns on its profitability. SPAI does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

SPAI had negative earnings in the past year.
SPAI had a negative operating cash flow in the past year.
SPAI Yearly Net Income VS EBIT VS OCF VS FCFSPAI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 0 -2M -4M -6M

1.2 Ratios

SPAI's Return On Assets of -278.02% is on the low side compared to the rest of the industry. SPAI is outperformed by 95.65% of its industry peers.
SPAI's Return On Equity of -387.74% is on the low side compared to the rest of the industry. SPAI is outperformed by 84.06% of its industry peers.
Industry RankSector Rank
ROA -278.02%
ROE -387.74%
ROIC N/A
ROA(3y)-115.38%
ROA(5y)N/A
ROE(3y)-188.96%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SPAI Yearly ROA, ROE, ROICSPAI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 -100 -200 -300

1.3 Margins

The Gross Margin of SPAI (41.26%) is better than 82.61% of its industry peers.
SPAI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 41.26%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SPAI Yearly Profit, Operating, Gross MarginsSPAI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 0 -200 -400 -600

5

2. Health

2.1 Basic Checks

SPAI does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for SPAI has been increased compared to 1 year ago.
SPAI has a better debt/assets ratio than last year.
SPAI Yearly Shares OutstandingSPAI Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 5M 10M
SPAI Yearly Total Debt VS Total AssetsSPAI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 1M 2M 3M 4M

2.2 Solvency

An Altman-Z score of 57.45 indicates that SPAI is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 57.45, SPAI belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
A Debt/Equity ratio of 0.06 indicates that SPAI is not too dependend on debt financing.
The Debt to Equity ratio of SPAI (0.06) is better than 82.61% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF N/A
Altman-Z 57.45
ROIC/WACCN/A
WACC9.7%
SPAI Yearly LT Debt VS Equity VS FCFSPAI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 2M -2M -4M

2.3 Liquidity

A Current Ratio of 1.70 indicates that SPAI should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.70, SPAI is in line with its industry, outperforming 40.58% of the companies in the same industry.
SPAI has a Quick Ratio of 1.34. This is a normal value and indicates that SPAI is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.34, SPAI is in line with its industry, outperforming 43.48% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.7
Quick Ratio 1.34
SPAI Yearly Current Assets VS Current LiabilitesSPAI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 500K 1M 1.5M 2M 2.5M

1

3. Growth

3.1 Past

SPAI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -53.62%.
The Revenue has grown by 136.37% in the past year. This is a very strong growth!
EPS 1Y (TTM)-53.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-225.94%
Revenue 1Y (TTM)136.37%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-39.94%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SPAI Yearly Revenue VS EstimatesSPAI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 500K 1M 1.5M 2M

0

4. Valuation

4.1 Price/Earnings Ratio

SPAI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SPAI Price Earnings VS Forward Price EarningsSPAI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SPAI Per share dataSPAI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.2 -0.4 -0.6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for SPAI!.
Industry RankSector Rank
Dividend Yield N/A

SAFE PRO GROUP INC

NASDAQ:SPAI (9/22/2025, 1:58:08 PM)

7.11

+0.16 (+2.3%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners1.3%
Inst Owner Change3.31%
Ins Owners51.36%
Ins Owner Change1.8%
Market Cap129.19M
AnalystsN/A
Price Target13.26 (86.5%)
Short Float %0.64%
Short Ratio0.18
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 63.13
P/FCF N/A
P/OCF N/A
P/B 48.87
P/tB 152.15
EV/EBITDA N/A
EPS(TTM)-0.8
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.28
FCFYN/A
OCF(TTM)-0.25
OCFYN/A
SpS0.11
BVpS0.15
TBVpS0.05
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -278.02%
ROE -387.74%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 41.26%
FCFM N/A
ROA(3y)-115.38%
ROA(5y)N/A
ROE(3y)-188.96%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.56
Health
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.7
Quick Ratio 1.34
Altman-Z 57.45
F-Score5
WACC9.7%
ROIC/WACCN/A
Cap/Depr(3y)55.18%
Cap/Depr(5y)N/A
Cap/Sales(3y)8.56%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-53.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-225.94%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)136.37%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-39.94%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-13.4%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-122.79%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-104.37%
OCF growth 3YN/A
OCF growth 5YN/A